Keytruda Immunotherapy: Mechanism, Cost, Risks, and Access
Why in the News ? The drug Keytruda is in focus after an investigation revealed a rising counterfeit market in India, along with concerns over its high cost, limited accessibility, and regulatory gaps, amid increasing cancer burden and growing demand for advanced immunotherapy treatments. Keytruda and Immunotherapy: Working and Benefits: Cost, Accessibility, and Counterfeit Concerns…
